Koru Medical Systems, INC Form 4 insider transactions

Horton Capital Partners Fund, L.P. distributed 14,317 shares of KORU Medical Systems common stock to its limited partners on May 20, 2025.

Linda Tharby, CEO of KORU Medical Systems, reports disposition of shares to cover tax obligations upon vesting of restricted stock.

Director Shahriar Matin of KORU Medical Systems, Inc. reports acquisition of 5,870 shares of common stock at $2.56 per share on April 2, 2025.

Director Edward Wholihan of KORU Medical Systems reports acquiring 5,870 shares of common stock at $2.56 per share.

Director Donna French of KORU Medical Systems, Inc. reports acquiring 5,870 shares of common stock at $2.56 per share on April 2, 2025, bringing her total holdings to 80,785 shares.

Director John Fletcher reports acquiring 8,806 shares of Koru Medical Systems at $2.56 per share, bringing his total holdings to 205,562 shares.

Director Robert Cascella acquired 5,870 shares of KORU Medical Systems at $2.56 per share on April 2, 2025, and now beneficially owns 80,426 shares.

Joseph M. Manko Jr., a director and 10% owner of KORU Medical Systems, reported the acquisition of 5,870 shares and disposal of 517,200 shares of common stock on March 31, 2025.

Linda Tharby, CEO of KORU Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding, affecting her beneficial ownership.

Christopher Pazdan, COO of Koru Medical Systems, reports the vesting and settlement of restricted stock units and performance share units, along with associated tax withholding.

Kenneth E. Miller, Chief Commercial Officer of KORU Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding.

Thomas Edward Adams, CFO of Koru Medical Systems, reports the vesting of restricted stock units and subsequent tax withholding.

Horton Capital Partners Fund, L.P. distributed 16,187 shares of KORU Medical Systems, Inc. common stock to its limited partners on February 6, 2025.

Joseph M. Manko Jr., a director and 10% owner of Koru Medical Systems, reported a series of share transfers involving Horton Capital entities, resulting in a net change in his direct and indirect holdings.

Director Shahriar Matin acquired 3,937 shares of KORU Medical Systems at $3.81 per share on January 3, 2025, increasing his direct holdings to 77,545 shares.

Director Edward Wholihan of KORU Medical Systems, Inc. reports acquiring 3,937 shares of common stock at $3.81 per share on January 3, 2025.

Director Robert Cascella of KORU Medical Systems, Inc. reports the acquisition of 3,937 shares of common stock at $3.81 per share on January 3, 2025.

John Fletcher, a director at Koru Medical Systems, reported acquiring 5,905 shares of common stock at $3.81 per share on January 3, 2025.

Director Donna French of KORU Medical Systems, Inc. reports acquiring 3,937 shares of common stock at $3.81 per share on January 3, 2025.

Joseph M. Manko Jr., a director of KORU Medical Systems, received 3,937 shares of common stock for his board service during the quarter ended December 31, 2024, while Horton Capital Partners Fund, LP, disposed of 165,252 shares.

A Koru Medical Systems director amended a previous SEC filing to correct the number of shares beneficially owned following a transaction.

A Koru Medical Systems director amended a previous SEC filing to correct the number of shares beneficially owned following a recent transaction.

Director Edward Wholihan of KORU Medical Systems reports the acquisition and disposal of common stock on October 1, 2024.

Director Shahriar Matin reports acquisition of 5,454 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.

Director Donna French of KORU Medical Systems, Inc. acquired 5,454 shares of common stock at $2.75 per share on October 1, 2024.

Director John Fletcher acquired 8,181 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.

Director Robert Cascella acquired 5,454 shares of KORU Medical Systems at $2.75 per share on October 1, 2024.

Joseph M. Manko, Jr., a director of KORU Medical Systems, received 5,454 shares of common stock for his service during the quarter ended September 30, 2024.

CEO Linda Tharby reports the acquisition of restricted stock units and stock options in KORU Medical Systems.

Chief Operating Officer Christopher Pazdan reports the acquisition of restricted stock units and options in KORU Medical Systems, Inc.